OSIP-486823 is a novel microtubule-disrupting agent with biological activity against both protein kinase G (PKG) and microtubules; it inhibits growth and induces apoptosis in SW480 human colon cancer cells (IC50 = 0.1 μM); causes depolymerization of microtubules in interphase cells, inhibits spindle formation in mitotic cells, and induces multinucleated cells; disrupts microtubule polymerization, perturbs mitotic spindle function, and arrests cells in mitosis in human glioma cells; it belongs to a new class of selective apoptotic antineoplastic drugs targeting cyclic guanosine 3′,5′-monophosphate phosphodiesterases (cGMP-PDE).